Davita Inc vs VanEck Junior Gold Miners — how do they compare? Davita Inc trades at $179.25 (market cap $11.29B), while VanEck Junior Gold Miners trades at $114.43 (market cap $8.22B). The key difference: Davita Inc is the larger of the two by market cap, and Davita Inc is trading nearer its 52-week high, VanEck Junior Gold Miners nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 114 Days and VanEck Junior Gold Miners for 41 Days on average.
| DVA | GDXJ | |
|---|---|---|
Market Cap | $11.29B | $8.22B |
Volume | 582,204 | 3,212,198 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $240.96 | $156.19 |
52-Week Low | $103.87 | $87.56 |
Typical Hold Time | 114 Days | 41 Days |
Enterprise Value | $24.01B | — |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, up 0.14% with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with 32.36% gross margins and 635.3% ROE, though net income margin declined to 5.47% in 2025. Recent partnership expansions with Humana for value-based kidney care and institutional buying by BlackRock provide positive catalysts. Valuation appears reasonable with P/E of 15 and P/S of 0.88, below sector averages.
Outlook remains mixed with analyst consensus target of $235.67 suggesting 33% upside, but technical indicators signal near-term caution. Key risks include regulatory pressures on healthcare reimbursements and rising debt-to-asset ratio reaching 65.55%. Earnings momentum from three consecutive quarterly beats supports fundamental strength, though margin compression warrants monitoring.
GDXJ, the VanEck Junior Gold Miners ETF, trades at $110.91, up 1.62% today. The technical outlook is bearish with moving averages signaling a downtrend, while oscillators are neutral. Recent news highlights multiple junior gold mining companies being added to the ETF's index, potentially broadening its investor base. Key support is at $110, with resistance at $112.
The outlook remains cautious due to the bearish technical structure and reliance on gold price volatility. Opportunities exist if gold rallies, but risks include sector-specific volatility and macroeconomic factors affecting mining stocks. Investor sentiment is mixed, with institutional activity showing some selling pressure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →